Registration Statement · S-1
AIxCrypto Holdings, Inc.
AIXCNASDAQEQUITYCurrent
Registration Statement
Company context
We are an early-clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancer. Our business now consists of one early-clinical-stage therapeutic program (QN-302) and one preclinical therapeutic program (Pan-RAS).
Current securities
As-filed source
As filedOpen full document ↗